Amphista Lands Megadeals to Smash Cancer using Protein Degradation
As big pharma companies flock to drugs that destroy harmful proteins, the UK protein degradation…
05/05/2022 - 3 minutes
Merck
Artios’ €129M Series C Pushes Limits of DNA Repair in Cancer
The UK firm Artios Pharma raised a huge Series C round last week in one…
06/08/2021 - 4 minutes
Sponsored
by Merck
You Need to Reach Market Readiness? What Now?
Advancing a drug to market readiness is a major milestone. After successfully completing clinical studies,…
11/05/2021 - 6 minutes
Sponsored
by Merck
Afraid of Tech Transfer? There’s No Need!
Tech transfer appears on the agenda of almost every biotech company. After identifying a suitable…
17/03/2021 - 6 minutes
Sponsored
by Merck
Bioburden Detection: The Hidden Bottleneck in Drug Manufacturing
Bioburden detection is one of the quality control measures required to ensure drug safety –…
07/09/2020 - 5 minutes
Sponsored
by Merck
The Roller Coaster of Gene Therapy Manufacturing
By 2027, the global gene therapy market is estimated to reach a staggering value of…
13/05/2020 - 9 minutes
Sponsored
by Merck
How to Overcome the Challenges in Biologics Development
By 2021, the global biologics market is expected to reach a value of $319B. But…
15/04/2020 - 2 minutes
Sponsored
by Merck
Gene Therapies: Overcoming the Biggest Hurdles in Manufacturing
By 2024, the gene therapy market is expected to reach an estimated worth of $13B…
16/03/2020 - 2 minutes
Merck Spinout Bags €15M Series A to Tackle Cancer and Fibrosis
iOnctura, a spinout from Merck KGaA, has raised €15M to take its cancer and fibrosis…
23/01/2020 - 2 minutes
International Collaboration on Brink of Resurrecting Northern White Rhinos
An international collaboration called BioRescue has taken a step forward in bringing back the Northern…
17/01/2020 - 3 minutes
Update: First Ever Ebola Vaccine Gets US and EU Approval
Update (20/12/2019): After getting conditional approval in Europe in November, Merck has received FDA approval…
20/12/2019 - 2 minutes
UK Company and Merck Team Up to Develop Vaccines Based on the Microbiome
Merck will pay the microbiome company 4D Pharma up to €316.5M to develop vaccines based…
08/10/2019 - 2 minutes
